Sponsor Pipeline

China Immunotech (Beijing) Biotechnology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
7
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1
7
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06943937 A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus Lupus Nephritis (LN) Recruiting
NCT06978647 A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases Systemic Lupus Erythematosus (SLE) Recruiting
NCT07104721 A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases Systemic Lupus Erythematosus (SLE) Recruiting
NCT07123519 A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases Systemic Lupus Erythematosus (SLE) Recruiting
NCT07236801 Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases Systemic Lupus Erythematosus (SLE) Recruiting
NCT07236762 An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases Systemic Lupus Erythematosus Recruiting
NCT07453836 Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia Autoimmune Hemolytic Anemia Not Yet Recruiting
Not specified
NCT06379646 An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory… Systemic Lupus Erythematosus Recruiting
Disease Areas
Get alerts when China Immunotech (Beijing) Biotechnology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free